FLT3 and acute myeloid leukemia: Herein, we review the known oncogenic signaling pathways modulated in FLT3 mutant AML, and the roles that each of the different FLT3 mutations play in the emergence of targeted-therapy resistance following the use of first and second generation TKIs.